Literature DB >> 10086359

CBP-independent activation of CREM and CREB by the LIM-only protein ACT.

G M Fimia1, D De Cesare, P Sassone-Corsi.   

Abstract

Transcriptional activation by CREB and CREM requires phosphorylation of a serine residue within the activation domain (Ser 133 in CREB; Ser 117 in CREM) which as a result interacts with the coactivator CBP. The activator CREM is highly expressed in male germ cells and is required for post-meiotic gene expression. Using a two-hybrid screen, we have isolated a testis-derived complementary DNA encoding a protein that we term ACT (for activator of CREM in testis), a LIM-only protein which specifically associates with CREM. ACT is expressed coordinately with CREM in a tissue- and developmentally regulated manner. It strongly stimulates CREM transcriptional activity in yeast and mammalian cells and contains an intrinsic activation function. As ACT bypasses the classical requirements for activation, namely phosphorylation of Ser 117 and interaction with CBP, it represents a new route for transcriptional activation by CREM and CREB. ACT may define a previously undiscovered class of tissue-specific coactivators whose function could be specific for distinct cellular differentiation programmes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086359     DOI: 10.1038/18237

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

Review 2.  Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB.

Authors:  P Haus-Seuffert; M Meisterernst
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

4.  FHL3 negatively regulates human high-affinity IgE receptor beta-chain gene expression by acting as a transcriptional co-repressor of MZF-1.

Authors:  Kyoko Takahashi; Chiyuki Matsumoto; Chisei Ra
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

5.  Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.

Authors:  Charlotte Labalette; Claire-Angélique Renard; Christine Neuveut; Marie-Annick Buendia; Yu Wei
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1.

Authors:  Aurore Morlon; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

7.  Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity.

Authors:  Valérie Serazin; Esther Dos Santos; Mireille Morot; Yves Giudicelli
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

8.  Novel role for a sterol response element binding protein in directing spermatogenic cell-specific gene expression.

Authors:  Hang Wang; Jovenal T San Agustin; George B Witman; Daniel L Kilpatrick
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.

Authors:  Thomas Günther; Cecilia Poli; Judith M Müller; Philip Catala-Lehnen; Thorsten Schinke; Na Yin; Sandra Vomstein; Michael Amling; Roland Schüle
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

10.  Abnormal sperm in mice with targeted deletion of the act (activator of cAMP-responsive element modulator in testis) gene.

Authors:  Noora Kotaja; Dario De Cesare; Betina Macho; Lucia Monaco; Stefano Brancorsini; Ellen Goossens; Herman Tournaye; Anne Gansmuller; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.